TransMedics Facing 'Misplaced' Concerns Over Increasing Jet Fuel Prices, Oppenheimer Says

MT Newswires Live04-07

TransMedics Group (TMDX) is facing "misplaced" concerns over increasing jet fuel prices' impact on its logistics margins, Oppenheimer said in a Tuesday note.

Based on conversations with industry players, Oppenheimer said TransMedics is passing on incremental fuel surcharges of up to $5,000 per flight to hospitals. The investment firm said "surcharge pass-throughs" is standard in hospital contracts for organ transplant logistics providers.

Even if the company had to shoulder the incremental costs, the estimated total impact in Q1 is about $2.5 million to $5 million based on flight hours, the brokerage added. A $5 million impact will cut Q1 gross margins by 270 basis points and earnings per share by about 15%, Oppenheimer added.

Oppenheimer has an outperform rating on TransMedics Group, with a $175 price target.

Price: 106.79, Change: +1.99, Percent Change: +1.89

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2625381952?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-07 23:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2625381952","market":"fut","top_or_hot":-1,"title":"TransMedics Facing 'Misplaced' Concerns Over Increasing Jet Fuel Prices, Oppenheimer Says","media":"MT Newswires Live","content":"<html><body><p> TransMedics Group (TMDX) is facing \"misplaced\" concerns over increasing jet fuel prices' impact on its logistics margins, Oppenheimer said in a Tuesday note.</p><p>Based on conversations with industry players, Oppenheimer said TransMedics is passing on incremental fuel surcharges of up to $5,000 per flight to hospitals. The investment firm said \"surcharge pass-throughs\" is standard in hospital contracts for organ transplant logistics providers.</p><p>Even if the company had to shoulder the incremental costs, the estimated total impact in Q1 is about $2.5 million to $5 million based on flight hours, the brokerage added. A $5 million impact will cut Q1 gross margins by 270 basis points and earnings per share by about 15%, Oppenheimer added.</p><p>Oppenheimer has an outperform rating on TransMedics Group, with a $175 price target.</p><p>Price: 106.79, Change: +1.99, Percent Change: +1.89</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TransMedics Facing 'Misplaced' Concerns Over Increasing Jet Fuel Prices, Oppenheimer Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTransMedics Facing 'Misplaced' Concerns Over Increasing Jet Fuel Prices, Oppenheimer Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-04-07 23:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> TransMedics Group (TMDX) is facing \"misplaced\" concerns over increasing jet fuel prices' impact on its logistics margins, Oppenheimer said in a Tuesday note.</p><p>Based on conversations with industry players, Oppenheimer said TransMedics is passing on incremental fuel surcharges of up to $5,000 per flight to hospitals. The investment firm said \"surcharge pass-throughs\" is standard in hospital contracts for organ transplant logistics providers.</p><p>Even if the company had to shoulder the incremental costs, the estimated total impact in Q1 is about $2.5 million to $5 million based on flight hours, the brokerage added. A $5 million impact will cut Q1 gross margins by 270 basis points and earnings per share by about 15%, Oppenheimer added.</p><p>Oppenheimer has an outperform rating on TransMedics Group, with a $175 price target.</p><p>Price: 106.79, Change: +1.99, Percent Change: +1.89</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OPY","symbol_name":"奥本海默控股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2625381952","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2625381952","pubTimestamp":1775577421,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"TransMedics Group  is facing \"misplaced\" concerns over increasing jet fuel prices' impact on its logistics margins, Oppenheimer said in a Tuesday note.Based on conversations with industry players, Oppenheimer said TransMedics is passing on incremental fuel surcharges of up to $5,000 per flight to hospitals. The investment firm said \"surcharge pass-throughs\" is standard in hospital contracts for organ transplant logistics providers.Even if the company had to shoulder the incremental costs, the estimated total impact in Q1 is about $2.5 million to $5 million based on flight hours, the brokerage added. A $5 million impact will cut Q1 gross margins by 270 basis points and earnings per share by about 15%, Oppenheimer added.Oppenheimer has an outperform rating on TransMedics Group, with a $175 price target.Price: 106.79, Change: +1.99, Percent Change: +1.89","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OPY":"奥本海默控股","BK4082":"医疗保健设备","BK4127":"投资银行业与经纪业","TMDX":"Transmedics Group","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","BK4588":"碎股","BK4585":"ETF&股票定投概念","LU2065731478.USD":"ALLSPRING (LUX) WORLDWIDE FUND - SMALL CAP INNOVA \"I\" (USD) ACC"},"translate_title":"奥本海默表示，TransMedics面临着对航空燃油价格上涨的“错误”担忧","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OPY":1.5,"TMDX":1},"content_text":"TransMedics Group (TMDX) is facing \"misplaced\" concerns over increasing jet fuel prices' impact on its logistics margins, Oppenheimer said in a Tuesday note.Based on conversations with industry players, Oppenheimer said TransMedics is passing on incremental fuel surcharges of up to $5,000 per flight to hospitals. The investment firm said \"surcharge pass-throughs\" is standard in hospital contracts for organ transplant logistics providers.Even if the company had to shoulder the incremental costs, the estimated total impact in Q1 is about $2.5 million to $5 million based on flight hours, the brokerage added. A $5 million impact will cut Q1 gross margins by 270 basis points and earnings per share by about 15%, Oppenheimer added.Oppenheimer has an outperform rating on TransMedics Group, with a $175 price target.Price: 106.79, Change: +1.99, Percent Change: +1.89","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2625381952","isCrawlerRequest":true}